Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$381.09 - $495.99 $69,358 - $90,270
182 Added 41.65%
619 $280,000
Q1 2024

May 14, 2024

SELL
$308.3 - $463.55 $52,719 - $79,267
-171 Reduced 28.13%
437 $202,000
Q4 2023

Feb 14, 2024

BUY
$289.29 - $409.7 $175,888 - $249,097
608 New
608 $230,000
Q4 2019

Feb 14, 2020

SELL
$688.5 - $846.15 $275,400 - $338,460
-400 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$837.83 - $927.0 $83,783 - $92,700
-100 Reduced 20.0%
400 $341,000
Q3 2018

Nov 13, 2018

SELL
$602.8 - $699.6 $30,139 - $34,980
-50 Reduced 9.09%
500 $340,000
Q1 2018

May 14, 2018

SELL
$526.8 - $633.85 $13,169 - $15,846
-25 Reduced 4.35%
550 $347,000
Q2 2017

Aug 14, 2017

BUY
N/A
575
575 $370,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.